Study of Efficacy and Safety of CTL019 in Adult DLBCL Patients

Name: Study of Efficacy and Safety of CTL019 in Adult DLBCL Patients
Published: 2015
License: Public Domain

Novartis Pharmaceuticals · 2015

ClinicalTrials.gov · Datasets · License: Public Domain · 2015

Open Source ↗

car-t-cells

diffuse large b-cell lymphoma (dlbcl), diffuse large b-cell lymphoma, dlbcl, relapsed/refractory, ctl019, cart19, cart, car t cells, chimeric antigen receptor, interventional, phase2

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Study of Efficacy and Safety of CTL019 in Adult DLBCL Patients

Related documents